Documenting the selection of quadrupedal walking gaits in a spread of marsupials (arboreal vs. terrestrial, with and with out greedy hind toes), to help in creating and refining a normal concept of gait evolution in primates.Video information of koalas, ringtail possums, tree kangaroos, sugar gliders, squirrel gliders, wombats, numbats, quolls, a thylacine, and an opossum walking on a spread of substrates had been made and analyzed to derive obligation elements and diagonalities for symmetrical walking gaits.
The ensuing distributions of knowledge factors had been in contrast with revealed knowledge and theories.Terrestrial marsupials’ gaits overwhelmingly plot barely beneath the theoretical “horse line” (Cartmill et al., Zoological Journal of the Linnean Society. 2002;136:401-420) typical of terrestrial mammals; arboreal marsupials’ gaits overwhelmingly plot extra decisively above it.
Both distributions are roughly parallel to the horse line, however arboreal animals exhibit elevated diagonality, in order that their higher-speed walking gaits overlap with these of typical primates on the Hildebrand diagram of diagonality in opposition to obligation issue.Quadrupeds keep away from gaits mendacity precisely on the (theoretically optimum) horse line, to keep away from fore/hind limb interference (“forging”).
This may be achieved by both a slight discount in diagonality (“downshifting”) or a extra decisive enhance (“upshifting”). Tree-dwellers undertake the second choice to get rid of unilateral bipods of assist from the gait cycle. The upshifted horse line represents an early part in the evolution of primate-like diagonal-sequence gaits.
Microbiological survey of sugar gliders (Petaurus breviceps) saved as pets in Italy.
The sugar glider (Petaurus breviceps) is a small, arboreal, nocturnal, gliding mammalian possum belonging to the marsupial infraclass. Exotic marsupials, together with sugar gliders, have gotten common companion pets and, consequently, the danger of potential infections that may be transmitted to people must be investigated.
Data on the position of the sugar glider as a potential provider of pathogenic and zoonotic micro organism are scarce and fragmentary. Therefore, this examine is aimed toward evaluating the prevalence of doubtlessly zoonotic micro organism (Salmonella spp., Escherichia coli, Campylobacter spp., Pseudomonas spp., Klebsiella spp., Listeria monocytogenes and Yersinia enterocolitica) in 64 sugar gliders saved as pets in Italy.
The highest prevalence of an infection pertained to members of the household Enterobacteriaceae, in specific Citrobacter spp. (50%), Enterobacter spp. (28.1%) and Klebsiella pneumoniae (15.6%); Pseudomonas aeruginosa was remoted from 10 out of 64 samples (15.6%). All strains of Klebsiella pneumoniae exhibited some stage of resistance to a number of antimicrobials (ampicillin, amoxicillin-clavulanic acid and doxycycline).
Diseases of the urinary tract are reviewed, protecting infectious (bacterial, viral, parasitic), degenerative, congenital, metabolic, dietary, neoplastic, obstructive, and poisonous causes. Some medical shows and diagnostic procedures are described for ferrets, rabbits, guinea pigs, hamsters, mice, rats, chinchillas, hedgehogs, and sugar gliders, in addition to therapies.
Morphology of the Lingual Papillae of the Japanese lesser flying squirrel and four-toed hedgehog.
Author examined the dorsal lingual surfaces of the grownup Japanese lesser flying squirrel (Pteromys momonga) and four-toed hedgehog (Atelerix albiventris) by scanning electron microscopy. In the Japanese lesser flying squirrel, the filiform papilla of the lingual physique consisted of a big conical papilla. The filiform papilla of the lingual prominence was spoon in form.
The fungiform papillae had been spherical in form and scattered amongst the filiform papillae. Many foliate papillae had been noticed on the posterolateral areas of the lingual physique. The foliate papillae had some ridges separated by deep grooves. The vallate papilla was positioned between lingual physique and root. Several lengthy conical papillae derived from the posterolateral margin of the tongue. In the four-toed hedgehog, the filiform papilla of the lingual apex had a conical course of.
The filiform papilla of the lingual physique had some processes. The fungiform papillae had been spherical in form. The foliate papillae had been noticed on the posterolateral areas of the lingual physique. The papilla was separated from one another by a furrow. The vallate papilla consisted of a central papilla and an annular pad.
These findings recommend that in the construction of the lingual papillae of the Japanese lesser flying squirrel there may be much like that of the sugar glider and the lingual papillae of the four-toed hedgehog is totally different from that of the Japanese lesser flying squirrel.
Swift declines predicted following mating system modifications pushed by an launched predator.
In Focus: Heinsohn, R., Olah, G., Webb, M., Peakall, R., & Stojanovic, D. (2019). Sex ratio bias and shared paternity scale back particular person health and inhabitants viability in a critically endangered parrot. Journal of Animal Ecology, 88, 502-510. While the results of variation in the intercourse ratio of offspring have been completely explored over the final century, the intercourse ratio of adults has obtained far much less consideration.
A paper by Heinsohn and colleagues in this problem exhibits that modifications in the grownup intercourse ratio can have hanging results on mating techniques, reproductive success and inhabitants viability. These impacts are all the extra dramatic as a result of they happen in a critically endangered species, the swift parrot, Lathamus discolor, of Tasmania.
This species suffers heavy predation from the launched sugar glider, Petaurus breviceps, which kills nesting females and their clutches, ensuing in strongly male-biased grownup intercourse ratios.
 Rat SLC50A1 shRNA Plasmid |
|
20-abx988744 |
Abbexa |
|
|
- Shipped within 15-20 working days.
|
 Mouse SLC50A1 shRNA Plasmid |
|
20-abx972446 |
Abbexa |
|
|
- Shipped within 15-20 working days.
|
 Human SLC50A1 shRNA Plasmid |
|
20-abx961032 |
Abbexa |
|
|
- Shipped within 15-20 working days.
|
) SLC50A1 Recombinant Protein (Rat) |
|
RP229691 |
ABM |
100 ug |
Ask for price |
) SLC50A1 Recombinant Protein (Human) |
|
RP097482 |
ABM |
100 ug |
Ask for price |
) SLC50A1 Recombinant Protein (Mouse) |
|
RP173330 |
ABM |
100 ug |
Ask for price |
 Polyclonal SLC50A1 antibody - C-terminal region |
|
APR01528G |
Leading Biology |
0.05mg |
EUR 528 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SLC50A1 - C-terminal region. This antibody is tested and proven to work in the following applications: |
 (pORF)) Slc50a1 ORF Vector (Rat) (pORF) |
|
ORF076565 |
ABM |
1.0 ug DNA |
EUR 506 |
 (pORF)) SLC50A1 ORF Vector (Human) (pORF) |
|
ORF032495 |
ABM |
1.0 ug DNA |
Ask for price |
 (pORF)) Slc50a1 ORF Vector (Mouse) (pORF) |
|
ORF057778 |
ABM |
1.0 ug DNA |
EUR 506 |
 (OKEH02450)) SLC50A1 ELISA Kit (Human) (OKEH02450) |
|
OKEH02450 |
Aviva Systems Biology |
96 Wells |
EUR 779 |
|
Description: Description of target: ;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.098 ng/mL |
 (OKEH04196)) SLC50A1 ELISA Kit (Rat) (OKEH04196) |
|
OKEH04196 |
Aviva Systems Biology |
96 Wells |
EUR 662 |
|
Description: Description of target: Mediates sugar transport across membranes. May stimulate V(D)J recombination by the activation of RAG1 (By similarity).;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.094 ng/mL |
 (OKEH04197)) SLC50A1 ELISA Kit (Mouse) (OKEH04197) |
|
OKEH04197 |
Aviva Systems Biology |
96 Wells |
EUR 662 |
|
Description: Description of target: Mediates sugar transport across membranes (By similarity). May regulate the expression of RAG1 a gene involved in V(D)J recombination;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 39.4 pg/mL |
) Slc50a1 sgRNA CRISPR Lentivector set (Rat) |
|
K7600101 |
ABM |
3 x 1.0 ug |
EUR 339 |
) SLC50A1 sgRNA CRISPR Lentivector set (Human) |
|
K2804901 |
ABM |
3 x 1.0 ug |
EUR 339 |
) Slc50a1 sgRNA CRISPR Lentivector set (Mouse) |
|
K3828901 |
ABM |
3 x 1.0 ug |
EUR 339 |
 ELISA Kit) Human Sugar transporter SWEET1 (SLC50A1) ELISA Kit |
|
abx251029-96tests |
Abbexa |
96 tests |
EUR 739 |
- Shipped within 5-12 working days.
|
 Rat Slc50a1/ Sugar transporter SWEET1 ELISA Kit |
|
E0914Ra |
Sunlong |
1 Kit |
Ask for price |
 Mouse Slc50a1/ Sugar transporter SWEET1 ELISA Kit |
|
E1373Mo |
Sunlong |
1 Kit |
EUR 632 |
 Human SLC50A1/ Sugar transporter SWEET1 ELISA Kit |
|
E2331Hu |
Sunlong |
1 Kit |
EUR 605 |
 ELISA Kit) Human SLC50A1(Sugar transporter SWEET1) ELISA Kit |
|
EH1727 |
FN Test |
96T |
EUR 567.6 |
- Detection range: 0.156-10 ng/ml
- Uniprot ID: Q9BRV3
- Alias: SLC50A1/Sugar transporter SWEET1/HsSWEET1/Stromal cell protein/RAG1-activating protein 1/Solute carrier family 50 member 1/RAG1AP1/SCP
|
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
 Human Sugar transporter SWEET1, SLC50A1 ELISA KIT |
|
ELI-29917h |
Lifescience Market |
96 Tests |
EUR 824 |
 ELISA Kit) Mouse Sugar transporter SWEET1 (SLC50A1) ELISA Kit |
|
abx517455-96tests |
Abbexa |
96 tests |
EUR 668 |
- Shipped within 5-12 working days.
|
 ELISA Kit) Rat Sugar transporter SWEET1 (SLC50A1) ELISA Kit |
|
abx517456-96tests |
Abbexa |
96 tests |
EUR 668 |
- Shipped within 5-12 working days.
|
 Mouse Sugar transporter SWEET1, Slc50a1 ELISA KIT |
|
ELI-41057m |
Lifescience Market |
96 Tests |
EUR 865 |
 (Target 1)) Slc50a1 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|
K7600102 |
ABM |
1.0 ug DNA |
EUR 154 |
 (Target 2)) Slc50a1 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|
K7600103 |
ABM |
1.0 ug DNA |
EUR 154 |
 (Target 3)) Slc50a1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|
K7600104 |
ABM |
1.0 ug DNA |
EUR 154 |
 (Target 1)) SLC50A1 sgRNA CRISPR Lentivector (Human) (Target 1) |
|
K2804902 |
ABM |
1.0 ug DNA |
EUR 154 |
 (Target 2)) SLC50A1 sgRNA CRISPR Lentivector (Human) (Target 2) |
|
K2804903 |
ABM |
1.0 ug DNA |
EUR 154 |
 (Target 3)) SLC50A1 sgRNA CRISPR Lentivector (Human) (Target 3) |
|
K2804904 |
ABM |
1.0 ug DNA |
EUR 154 |
 (Target 1)) Slc50a1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|
K3828902 |
ABM |
1.0 ug DNA |
EUR 154 |
 (Target 2)) Slc50a1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|
K3828903 |
ABM |
1.0 ug DNA |
EUR 154 |
 (Target 3)) Slc50a1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|
K3828904 |
ABM |
1.0 ug DNA |
EUR 154 |
 (pPB-C-His)) SLC50A1 Protein Vector (Human) (pPB-C-His) |
|
PV129978 |
ABM |
500 ng |
Ask for price |
 (pPB-N-His)) SLC50A1 Protein Vector (Human) (pPB-N-His) |
|
PV129979 |
ABM |
500 ng |
Ask for price |
 (pPM-C-HA)) SLC50A1 Protein Vector (Human) (pPM-C-HA) |
|
PV129980 |
ABM |
500 ng |
Ask for price |
 (pPM-C-His)) SLC50A1 Protein Vector (Human) (pPM-C-His) |
|
PV129981 |
ABM |
500 ng |
Ask for price |
 (pPB-C-His)) SLC50A1 Protein Vector (Rat) (pPB-C-His) |
|
PV306258 |
ABM |
500 ng |
EUR 603 |
 (pPB-N-His)) SLC50A1 Protein Vector (Rat) (pPB-N-His) |
|
PV306259 |
ABM |
500 ng |
EUR 603 |
 (pPM-C-HA)) SLC50A1 Protein Vector (Rat) (pPM-C-HA) |
|
PV306260 |
ABM |
500 ng |
EUR 603 |
 (pPM-C-His)) SLC50A1 Protein Vector (Rat) (pPM-C-His) |
|
PV306261 |
ABM |
500 ng |
EUR 603 |
 (pPB-C-His)) SLC50A1 Protein Vector (Mouse) (pPB-C-His) |
|
PV231110 |
ABM |
500 ng |
EUR 603 |
 (pPB-N-His)) SLC50A1 Protein Vector (Mouse) (pPB-N-His) |
|
PV231111 |
ABM |
500 ng |
EUR 603 |
 (pPM-C-HA)) SLC50A1 Protein Vector (Mouse) (pPM-C-HA) |
|
PV231112 |
ABM |
500 ng |
EUR 603 |
 (pPM-C-His)) SLC50A1 Protein Vector (Mouse) (pPM-C-His) |
|
PV231113 |
ABM |
500 ng |
EUR 603 |
 Slc50a1 3'UTR Luciferase Stable Cell Line |
|
TU119174 |
ABM |
1.0 ml |
Ask for price |
 Slc50a1 3'UTR GFP Stable Cell Line |
|
TU169174 |
ABM |
1.0 ml |
Ask for price |
Slc50a1 3'UTR Luciferase Stable Cell Line |
|
TU220696 |
ABM |
1.0 ml |
Ask for price |
Slc50a1 3'UTR GFP Stable Cell Line |
|
TU270696 |
ABM |
1.0 ml |
Ask for price |
 (CMV) (pLenti-GIII-CMV)) SLC50A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|
LV687895 |
ABM |
1.0 ug DNA |
EUR 514 |
 (UbC) (pLenti-GIII-UbC)) SLC50A1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|
LV687899 |
ABM |
1.0 ug DNA |
EUR 514 |
 (EF1a) (pLenti-GIII-EF1a)) SLC50A1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|
LV687900 |
ABM |
1.0 ug DNA |
EUR 514 |
) Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|
K7600105 |
ABM |
3 x 1.0 ug |
EUR 376 |
) SLC50A1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|
K2804905 |
ABM |
3 x 1.0 ug |
EUR 376 |
) Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|
K3828905 |
ABM |
3 x 1.0 ug |
EUR 376 |
 (CMV) (pLenti-GIII-CMV-C-term-HA)) SLC50A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|
LV687896 |
ABM |
1.0 ug DNA |
EUR 514 |
 (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)) SLC50A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|
LV687897 |
ABM |
1.0 ug DNA |
EUR 572 |
 (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)) SLC50A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|
LV687898 |
ABM |
1.0 ug DNA |
EUR 572 |
 (Target 1)) Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|
K7600106 |
ABM |
1.0 ug DNA |
EUR 167 |
 (Target 2)) Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|
K7600107 |
ABM |
1.0 ug DNA |
EUR 167 |
 (Target 3)) Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|
K7600108 |
ABM |
1.0 ug DNA |
EUR 167 |
 (Target 1)) SLC50A1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|
K2804906 |
ABM |
1.0 ug DNA |
EUR 167 |
 (Target 2)) SLC50A1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|
K2804907 |
ABM |
1.0 ug DNA |
EUR 167 |
 (Target 3)) SLC50A1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|
K2804908 |
ABM |
1.0 ug DNA |
EUR 167 |
 (Target 1)) Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|
K3828906 |
ABM |
1.0 ug DNA |
EUR 167 |
 (Target 2)) Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|
K3828907 |
ABM |
1.0 ug DNA |
EUR 167 |
 (Target 3)) Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|
K3828908 |
ABM |
1.0 ug DNA |
EUR 167 |
 H2B Antibody Antibody |
|
AF4659 |
Affbiotech |
200ul |
EUR 376 |
|
Description: H2B Antibody Antibody detects endogenous levels of H2B. |
 anti- Antibody^Polyclonal antibody control antibody |
|
LSMab09882 |
Lifescience Market |
100 ug |
EUR 438 |
 Antibody) Ly1 Antibody Reactive (LYAR) Antibody |
|
20-abx008109 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
- Shipped within 5-10 working days.
|
 Antibody) Anti-Glycolipid Antibody (AGA) Antibody |
|
20-abx004855 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
-
100 ul
-
200 ul
-
20 ul
-
50 ul
|
- Shipped within 5-10 working days.
|
Ly1 Antibody Reactive (LYAR) Antibody |
|
20-abx123734 |
Abbexa |
|
|
- Shipped within 5-10 working days.
|
Anti-Glycolipid Antibody (AGA) Antibody |
|
abx036399-100ug |
Abbexa |
100 ug |
EUR 391 |
- Shipped within 5-10 working days.
|
Ly1 Antibody Reactive (LYAR) Antibody |
|
20-abx014333 |
Abbexa |
-
EUR 314.00
-
EUR 98.00
-
EUR 398.00
-
EUR 495.00
|
-
100 ug
-
10 ug
-
200 ug
-
300 µg
|
- Shipped within 5-10 working days.
|
Ly1 Antibody Reactive (LYAR) Antibody |
|
abx033330-400ul |
Abbexa |
400 ul |
EUR 523 |
- Shipped within 5-10 working days.
|
Ly1 Antibody Reactive (LYAR) Antibody |
|
abx033330-80l |
Abbexa |
80 µl |
EUR 286 |
- Shipped within 5-10 working days.
|
 Antibody) Anti-Glycoprotein Antibody (GP) Antibody |
|
20-abx319900 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody |
|
20-abx319901 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody |
|
20-abx319905 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody |
|
20-abx319913 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Ly1 Antibody Reactive (LYAR) Antibody |
|
abx234901-100ug |
Abbexa |
100 ug |
EUR 551 |
- Shipped within 5-12 working days.
|
Ly1 Antibody Reactive (LYAR) Antibody |
|
20-abx324434 |
Abbexa |
|
|
- Shipped within 5-10 working days.
|
Ly1 Antibody Reactive (LYAR) Antibody |
|
20-abx311665 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycolipid Antibody (AGA) Antibody |
|
abx230204-100ug |
Abbexa |
100 ug |
EUR 481 |
- Shipped within 5-12 working days.
|
 Anti-Anti-SEPT6 antibody antibody |
|
STJ11100949 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
 Anti-Anti-SEPT9 Antibody antibody |
|
STJ111369 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
 Anti-Anti-SEPT4 Antibody antibody |
|
STJ112276 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
 Anti-Anti-SEPT5 Antibody antibody |
|
STJ25477 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
 Anti-Anti-SEPT8 Antibody antibody |
|
STJ25479 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
 Anti-Anti-SEPT7 Antibody antibody |
|
STJ28963 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT5 Antibody antibody |
|
STJ114819 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT7 Antibody antibody |
|
STJ116214 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT8 Antibody antibody |
|
STJ117206 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
 Anti-Anti-SEPT12 Antibody antibody |
|
STJ117759 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
 Anti-Anti-SEPT1 antibody antibody |
|
STJ119580 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
 Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|
48169-100ul |
SAB |
100ul |
EUR 333 |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|
48169-50ul |
SAB |
50ul |
EUR 239 |
 Antibody Pair to ApoA-V antibody |
|
10R-1876 |
Fitzgerald |
100 ul |
EUR 651 |
|
Description: Mouse monoclonal Antibody Pair to ApoA-V antibody |
 Anti CD22 Antibody: CD22 Monoclonal Antibody |
|
065-A-01mg |
Virogen |
0,1 mg |
EUR 267.5 |
- Category: Antibody, Signal Transduction Antibodies, mAb
|
|
Description: anti-CD22 monoclonal antibody |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|
065-A-1000ug |
Virogen |
1000 ug |
EUR 1282.5 |
- Category: Antibody, Signal Transduction Antibodies, mAb
|
|
Description: anti-CD22 monoclonal antibody |
 Antibody) Hepatitis C Virus Antibody (HCV) Antibody |
|
abx023924-1mg |
Abbexa |
1 mg |
EUR 1205 |
- Shipped within 5-10 working days.
|
 Antibody) Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|
20-abx103034 |
Abbexa |
-
EUR 453.00
-
EUR 133.00
-
EUR 1302.00
-
EUR 620.00
-
EUR 342.00
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
- Shipped within 5-7 working days.
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|
20-abx103035 |
Abbexa |
-
EUR 467.00
-
EUR 133.00
-
EUR 1344.00
-
EUR 634.00
-
EUR 342.00
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
- Shipped within 5-7 working days.
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|
20-abx103036 |
Abbexa |
-
EUR 481.00
-
EUR 133.00
-
EUR 1414.00
-
EUR 662.00
-
EUR 356.00
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
- Shipped within 5-7 working days.
|
 Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
|
AMM06679G |
Leading Biology |
0.05mg |
EUR 528 |
|
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
 Antibody) Anti Deoxyribonucleic Acid Antibody (DNA) Antibody |
|
abx411057-50ug |
Abbexa |
50 ug |
EUR 592 |
|
|
 Antibody (HRP)) Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|
20-abx319902 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
 Antibody (FITC)) Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|
20-abx319903 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
 Antibody (Biotin)) Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|
20-abx319904 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|
20-abx319906 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|
20-abx319907 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|
20-abx319908 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|
20-abx319914 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|
20-abx319915 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|
20-abx319916 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|
20-abx319929 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|
20-abx319930 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|
20-abx319931 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
 Antibody) Anti-Glycoprotein 210 Antibody (gp210) Antibody |
|
abx233571-100ug |
Abbexa |
100 ug |
EUR 481 |
- Shipped within 5-12 working days.
|
 Antibody (HRP)) Ly1 Antibody Reactive (LYAR) Antibody (HRP) |
|
20-abx311666 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
 Antibody (FITC)) Ly1 Antibody Reactive (LYAR) Antibody (FITC) |
|
20-abx311667 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
 Antibody (Biotin)) Ly1 Antibody Reactive (LYAR) Antibody (Biotin) |
|
20-abx311668 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
- Shipped within 5-10 working days.
|
 Goat anti- human Antibody^Polyclonal antibody |
|
LSMab09896 |
Lifescience Market |
100 ug |
EUR 438 |
 Antibody for Human alpha Tubulin Antibody |
|
SPC-692D |
Stressmarq |
0.1mg |
EUR 354 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is unconjugated. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-A390 |
Stressmarq |
0.1mg |
EUR 401 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 390. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-A488 |
Stressmarq |
0.1mg |
EUR 400 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 488. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-A565 |
Stressmarq |
0.1mg |
EUR 400 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 565. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-A594 |
Stressmarq |
0.1mg |
EUR 400 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 594. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-A633 |
Stressmarq |
0.1mg |
EUR 400 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 633. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-A655 |
Stressmarq |
0.1mg |
EUR 400 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 655. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-A680 |
Stressmarq |
0.1mg |
EUR 400 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 680. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-A700 |
Stressmarq |
0.1mg |
EUR 400 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 700. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-ALP |
Stressmarq |
0.1mg |
EUR 394 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Alkaline Phosphatase. |
Antibody for Human alpha Tubulin Antibody |
|
SPC-692D-APC |
Stressmarq |
0.1mg |
EUR 399 |
|
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to APC . |
The authors mixed demographic and genetic knowledge to indicate that, at websites with heavier predation, the remaining females had been extra more likely to mate with a number of males. This shift in the mating system additionally led to decrease general nesting success, with fewer chicks fledged per nest at websites with increased ranges of blended paternity.
